期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (3)
Chronic infection with the hepatitis B virus (HBV) is one of the most common causes of liver disease worldwide. Chronic HBV infection is currently inc......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (3)
Efficient and thorough care of hospitalized patients with advanced chronic liver disease is of utter importance to improve outcomes and optimize quali......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (1)
Metabolic rewiring is one of the hallmarks of cancer. Altered de novo lipogenesis is one of the pivotal metabolic events deregulated in cancers. Stero......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (3)
The biliary tree comprises intrahepatic bile ducts and extrahepatic bile ducts lined with epithelial cells known as biliary epithelial cells (BECs). B......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (4)
Liver cancer, mainly hepatocellular carcinoma (HCC), remains a major cause of cancer-related death worldwide. With the global epidemic of obesity, the......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (4)
Nonalcoholic fatty liver disease (NAFLD) and cardiovascular diseases are both highly prevalent conditions around the world, and emerging data have sho......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (4)
Early palliative and supportive care referral is the standard of care for many malignancies. This paradigm results in improvements in patients' sympto......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (4)
Diet could be both culprit and solution of NAFLD. Dietary modifications have been associated with histological features improvement in NAFLD. The West......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (3)
Promising preclinical data suggested that bone marrow-derived mesenchymal stem cells (BM-MSC) can reduce hepatic fibrosis and stimulate liver regenera......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (2)
[GRAPHICS] Alcohol use disorder (AUD) is one of themain causes of global death and disability. The liver represents themain target of alcohol damage, ......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (1)
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide with high prevalence, especially in individuals wi......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (2)
The complex immune system of the liver has a major role in tumor surveillance, but also partly explains why current immune therapies are poorly effect......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (3)
Cirrhosis is a risk factor for infections. Majority of hospital admissions in patients with cirrhosis are due to infections. Sepsis is an immunologica......
期刊： SEMINARS IN LIVER DISEASE, 2022; 42 (4)
Obesity is strongly associated with nonalcoholic fatty liver disease as well as advanced forms of the disease such as nonalcoholic steatohepatitis (NA......
